241 related articles for article (PubMed ID: 7706819)
1. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.
Ma J; Bulger PA; Dante S; Davis DR; Perilli-Palmer B; Coughlin RT
J Infect Dis; 1995 Apr; 171(4):909-15. PubMed ID: 7706819
[TBL] [Abstract][Full Text] [Related]
2. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS
Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
[TBL] [Abstract][Full Text] [Related]
3. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.
Coughlin RT; Fish D; Mather TN; Ma J; Pavia C; Bulger P
J Infect Dis; 1995 Apr; 171(4):1049-52. PubMed ID: 7706788
[TBL] [Abstract][Full Text] [Related]
4. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.
Schaible UE; Wallich R; Kramer MD; Gern L; Anderson JF; Museteanu C; Simon MM
Vaccine; 1993; 11(10):1049-54. PubMed ID: 8212826
[TBL] [Abstract][Full Text] [Related]
5. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
Aydintug MK; Gu Y; Philipp MT
Infect Immun; 1994 Nov; 62(11):4929-37. PubMed ID: 7927774
[TBL] [Abstract][Full Text] [Related]
6. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.
Ma J; Gingrich-Baker C; Franchi PM; Bulger P; Coughlin RT
Infect Immun; 1995 Jun; 63(6):2221-7. PubMed ID: 7539408
[TBL] [Abstract][Full Text] [Related]
8. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
Izac JR; Oliver LD; Earnhart CG; Marconi RT
Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
[TBL] [Abstract][Full Text] [Related]
9. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.
Kalish RA; Leong JM; Steere AC
Infect Immun; 1993 Jul; 61(7):2774-9. PubMed ID: 7685738
[TBL] [Abstract][Full Text] [Related]
10. Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine.
Ma J; Hine PM; Clough ER; Fish D; Coughlin RT; Beltz GA; Shew MG
Vaccine; 1996 Oct; 14(14):1366-74. PubMed ID: 9004447
[TBL] [Abstract][Full Text] [Related]
11. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
Zhong W; Gern L; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
[TBL] [Abstract][Full Text] [Related]
12. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis.
Akin E; McHugh GL; Flavell RA; Fikrig E; Steere AC
Infect Immun; 1999 Jan; 67(1):173-81. PubMed ID: 9864212
[TBL] [Abstract][Full Text] [Related]
13. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms.
Roehrig JT; Piesman J; Hunt AR; Keen MG; Happ CM; Johnson BJ
J Immunol; 1992 Dec; 149(11):3648-53. PubMed ID: 1431134
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of protective antibodies are generated against Borrelia burgdorferi in mice experimentally inoculated with high and low doses of antigen.
Schaible UE; Gern L; Wallich R; Kramer MD; Prester M; Simon MM
Immunol Lett; 1993 May; 36(2):219-26. PubMed ID: 8349316
[TBL] [Abstract][Full Text] [Related]
15. Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.
Liang FT; Caimano MJ; Radolf JD; Fikrig E
Microb Pathog; 2004 Jul; 37(1):35-40. PubMed ID: 15194158
[TBL] [Abstract][Full Text] [Related]
16. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
[TBL] [Abstract][Full Text] [Related]
17. Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
Lovrich SD; Callister SM; DuChateau BK; Lim LC; Winfrey J; Day SP; Schell RF
Infect Immun; 1995 Jun; 63(6):2113-9. PubMed ID: 7768589
[TBL] [Abstract][Full Text] [Related]
18. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.
Probert WS; LeFebvre RB
Infect Immun; 1994 May; 62(5):1920-6. PubMed ID: 8168958
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
20. Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection.
Barthold SW; Levy SA; Fikrig E; Bockenstedt LK; Smith AL
J Am Vet Med Assoc; 1995 Dec; 207(11):1435-40. PubMed ID: 7493871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
